Underlying NPAT rose 23.2% despite reported profit falling 10.0%

This is not a genuine earnings contraction: the company's own reported-to-underlying reconciliation shows FY25's reported result included a net gain on sale of Northport, and underlying group net profit rose 23.2% to a record $155.3m this year. The effective tax rate rose to 26.1% from 20.6%, adding further downward pressure on reported NPAT.

Capex jumped 208.5% to $86.7m from $28.1m, lifting capex intensity to 17.8% of revenue from 6.1%. Company-defined free cash flow fell to $118.7m from $142.4m even as operating cash flow rose 19.4% to $205.4m. Net debt to EBITDA improved to 1.66x from 1.96x.

The headline 10.0% NPAT decline is largely a comparability artefact from last year's Northport disposal gain rather than deteriorating trading; the reconciled underlying profit of $155.3m, up 23.2%, is the cleaner read on operating momentum, so investors should anchor on that figure rather than the reported year-on-year fall.

Capex step-up compressing free cash flow. Capex intensity rose to 17.8% of revenue from 6.1%, and company-defined free cash flow fell to $118.7m from $142.4m, cutting FCF-to-NPAT conversion to 76.1% from 83%. This matters because the business is now retaining less discretionary cash even though operating cash flow itself grew 19.4% and cash conversion held near normal at 74.5% versus 73.3% prior.

Dividend and payout escalation. The final dividend rose 28.9% to 12.5 cents, taking the full-year dividend to 20.5 cents from 16.7 cents, while the payout ratio against NPAT jumped to 88.7% from 65.0%. Distributions are now consuming a materially larger share of profit, which leaves less buffer to absorb the heavier capex programme without additional borrowing.

Management commentary points to broadly steady log export forecasts and continued growth expectations in some trades, but these are qualitative signals, not numeric commitments the result can be judged against.

The absence of forward guidance means the improved leverage position (net debt to EBITDA of 1.66x) and record underlying earnings are the main evidence available; whether the capex intensity of 17.8% of revenue is a one-year peak or a new multi-year run rate cannot be assessed from this filing alone.

The reported NPAT decline is less a quality issue than a comparability issue, given the disclosed Northport gain sitting in the prior year's base.

The less durable element is free cash flow, which fell on a 208.5% increase in capex, a step-change in investment spend rather than an established recurring pattern based on the two years shown. Receivable days extended to 57 from 51.8, a modest lengthening worth monitoring, though no historical baseline was supplied to judge whether this sits inside or outside a normal range.

This briefing cannot assess whether the FY27 capex programme will be funded from operating cash flow alone or will require incremental borrowing, since no forward capex or financing guidance was disclosed.